John C. Martin, 69, Dies; Led Drugmaker in Breakthroughs April 27, 2021 Auto Bot Acquired Immune Deficiency Syndrome, Deaths (Obituaries), hepatitis 0 A chemist by training, he turned Gilead Sciences into a leading, and lucrative, innovator with single-pill treatments for H.I.V. and hepatitis C.